CSLT · Castlight Health, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|
| Revenue | $146.71M | $143.31M | $98.71M | - | - | - |
| Cost of Revenue | $52.04M | $59.07M | $31.87M | - | - | - |
| Gross Profit | $94.67M | $84.23M | $96.22M | $84.25M | $67.14M | $41.55M |
| R&D | $49.47M | $58.99M | $61.35M | $54.50M | $40.46M | $30.08M |
| SG&A | $25.66M | $27.98M | $25.62M | $28.82M | $26.86M | $24.27M |
| Total Operating Expenses | $157.45M | $125.57M | $136.11M | $145.64M | $126.12M | $121.77M |
| D&A | $6.54M | $5.92M | $6.86M | $6.61M | $3.17M | $2.02M |
| Operating Income | ($62.79M) | ($41.34M) | ($39.89M) | ($61.40M) | ($58.98M) | ($80.22M) |
| Interest Expense | $200.0K | $300.0K | - | - | - | - |
| Income Tax | $0 | $0 | $0 | $5.21M | $0 | $0 |
| Net Income | ($62.18M) | ($40.00M) | ($39.71M) | ($55.57M) | ($58.55M) | ($79.92M) |
| EPS - Basic | - | - | - | - | - | - |
| EPS - Diluted | - | - | - | - | - | - |
Balance Sheet
| Line item | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $49.24M | $43.02M | $66.00M | $61.32M | $48.72M | $19.15M |
| Accounts Receivable | - | - | - | $20.76M | $14.81M | $12.75M |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | $5.14M | $19.60M | $9.56M | $3.91M | $2.29M | $3.38M |
| Current Assets | $84.78M | $95.47M | $107.83M | $124.50M | $141.01M | $142.38M |
| Total Assets | $166.77M | $242.78M | $253.51M | $249.30M | $157.17M | $173.27M |
| Current Liabilities | $34.31M | $54.91M | $51.18M | $60.44M | $48.72M | $46.00M |
| Long-term Debt | $0 | $1.40M | $3.25M | $4.96M | - | - |
| Total Liabilities | $42.91M | $69.91M | $58.84M | $73.98M | $55.20M | $54.92M |
| Stockholders' Equity | $123.87M | $172.87M | $194.67M | $175.32M | $101.96M | $118.35M |
| Retained Earnings | ($517.23M) | ($455.04M) | ($415.04M) | ($411.57M) | ($355.64M) | ($297.10M) |
Cash Flow
| Line item | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | ($5.57M) | ($17.39M) | ($18.55M) | ($23.46M) | ($36.97M) | ($56.87M) |
| Investing Cash Flow | $12.83M | ($6.80M) | $19.22M | $34.61M | $46.48M | $54.74M |
| Financing Cash Flow | ($1.22M) | $1.20M | $4.01M | $1.63M | $20.07M | $3.85M |
| CapEx | $3.58M | $1.95M | $2.01M | $2.54M | $1.70M | $5.38M |
| Free Cash Flow | ($9.14M) | ($19.34M) | ($20.57M) | ($26.00M) | ($38.67M) | ($62.24M) |
Ratios
| Metric | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 64.5% | 58.8% | 97.5% | - | - | - |
| Operating margin | -42.8% | -28.8% | -40.4% | - | - | - |
| EBITDA margin | -38.3% | -24.7% | -33.5% | - | - | - |
| Net margin | -42.4% | -27.9% | -40.2% | - | - | - |
| Free cash flow margin | -6.2% | -13.5% | -20.8% | - | - | - |
| FCF / Net income | 0.15 | 0.48 | 0.52 | 0.47 | 0.66 | 0.78 |
| R&D / Revenue | 33.7% | 41.2% | 62.2% | - | - | - |
| SG&A / Revenue | 17.5% | 19.5% | 26.0% | - | - | - |
| Effective tax rate | - | - | - | - | - | - |
| Return on assets | -37.3% | -16.5% | -15.7% | -22.3% | -37.3% | -46.1% |
| Return on equity | -50.2% | -23.1% | -20.4% | -31.7% | -57.4% | -67.5% |
| Return on invested capital | -40.0% | -18.7% | -15.9% | -26.9% | - | - |
| Liquidity | ||||||
| Current ratio | 2.47 | 1.74 | 2.11 | 2.06 | 2.89 | 3.10 |
| Quick ratio | 2.47 | 1.74 | 2.11 | 2.06 | 2.89 | 3.10 |
| Cash ratio | 1.44 | 0.78 | 1.29 | 1.01 | 1.00 | 0.42 |
| Leverage | ||||||
| Debt / Equity | 0.00 | 0.01 | 0.02 | 0.03 | - | - |
| Debt / Assets | 0.00 | 0.01 | 0.01 | 0.02 | - | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | -313.9x | -137.8x | - | - | - | - |
| Equity multiplier | 1.35 | 1.40 | 1.30 | 1.42 | 1.54 | 1.46 |
| Liabilities / Assets | 0.26 | 0.29 | 0.23 | 0.30 | 0.35 | 0.32 |
| Efficiency | ||||||
| Asset turnover | 0.88 | 0.59 | 0.39 | - | - | - |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | 36d | 121d | 109d | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | 2.4% | 45.2% | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - |
| Gross profit growth (YoY) | 12.4% | -12.5% | 14.2% | 25.5% | 61.6% | - |
| Operating income growth (YoY) | -51.9% | -3.6% | 35.0% | -4.1% | 26.5% | -128.3% |
| Net income growth (YoY) | -55.4% | -0.7% | 28.5% | 5.1% | 26.7% | -128.3% |
| EPS growth (YoY) | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - |
| FCF growth (YoY) | 52.7% | 5.9% | 20.9% | 32.8% | 37.9% | -109.0% |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | -28.3% | -11.2% | 11.0% | 71.9% | -13.8% | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2020-12-31.
Product / service
$146.71M totalSubscription And Circulation$141.16M · 96.2%
Professional Services And Other$5.55M · 3.8%
Stability scores
Altman Z′
FY 2020 · bankruptcy risk
-1.49
Distress
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2020 · 9-point quality
5/9
Neutral
- ✗Net income positive
- ✗Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- ✓Long-term debt decreased
- ✓Current ratio improved
- -No share dilution
- ✓Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Services-Computer Processing & Data Preparation
Comparing CASTLIGHT HEALTH against the 5 most active filers in the same SIC group.